Doruk Erkan, MD

Dr. Doruk Erkan is an Associate Physician-Scientist at the Barbara Volcker Center for Women and Rheumatic Diseases, Assistant Attending Rheumatologist and Clinical Researcher at Hospital for Special Surgery, and Assistant Professor of Medicine at Weill Cornell Medical College. In addition to his rheumatology practice, Dr. Erkan has a long-standing research interest in Antiphospholipid Syndrome (an autoimmune clotting disorder) and Systemic Lupus Erythematosus (SLE or “lupus”). After his Internal Medicine residency at Beth Israel Medical Center in New York, he completed his Rheumatology fellowship at Hospital for Special Surgery in New York. Dr. Erkan has a medical doctor (MD) degree from Hacettepe University School of Medicine in Ankara, Turkey and a master of public health (MPH) degree from Johns Hopkins University School of Public Health in Baltimore, Maryland. Dr. Erkan has received several honors and awards from the American College of Rheumatology and the Arthritis Foundation for his research. He has published over 80 articles including research papers and invited editorials, as well as 18 book chapters, and he has given over 100 research presentations. He is the co-editor of the Neurology volume of the Handbook of Systemic Autoimmune Disease and the Associate Editor of Hospital for Special Surgery’s Manual of Rheumatology and Outpatient Orthopedic Disorders.

Appointments

Assistant Attending Rheumatologist, Hospital for Special Surgery
Assistant Professor of Medicine, Weill Cornell Medical College
Associate Physician-Scientist, Barbara Volcker Center for Women and Rheumatic Disease
Clinical Co-Director, Mary Kirkland Center for Lupus Care

Specialty

Rheumatology

Special Expertise

Antiphospholipid syndrome
Systemic lupus erythematosus
Medical multimedia for physician and patient education

Awards

Lupus Research Award, New York Community Trust, 2008
Rudd-Gardy Teaching Excellence Award, HSS Division of Rheumatology, 2008
Young Investigator Award, AESKU.KIPP Institute, Germany, 2007
Young Investigator Initiative Award, US Bone and Joint Decade, 2006
Antiphospholipid Syndrome Research Award, New York Community Trust, 2004
Dorothy W. Goldstein Young Scholar Award, Arthritis Foundation, New York Chapter, 2002
Rheumatology Fellow Award, American College of Rheumatology, 2001
Postdoctoral Fellowship Award, Arthritis Foundation, New York Chapter, 2001

Affiliations

American College of Rheumatology, Fellow
New York Rheumatism Association, Executive Committee

Specialized Centers

• Mary Kirkland Center for Lupus Care
• Barbara Volcker Center for Women and Rheumatic Diseases

Education

Medical Doctor (MD), Hacettepe University School of Medicine, Ankara, Turkey
Master of Public Health (MPH), Johns Hopkins University School of Public Health, Baltimore, Maryland

Residency

Internal Medicine, Beth Israel Medical Center, New York

Fellowship

Rheumatology, Hospital for Special Surgery, New York

Certification

American Board of Rheumatology, 2001
Certificate in Clinical Epidemiology and Health Services Research, Weill Cornell Medical College, 2000
American Board of Internal Medicine, 1999

State Licensure

New York  

Doruk Erkan, MD is the author of the following articles on HSS.edu:

Selected Publications

Rheumatology Clinical Research Center (RCRC): Recent Publictions

For more publications, please see the PubMed listing.  

Research Description

Dr. Doruk Erkan has been involved in Antiphospholipid Syndrome (APS) research since 1997. His research interest includes identification of factors that increase the risk of blood clots and potential prevention strategies. He is the principal investigator in multiple clinical trials ranging from mechanistic studies to drug trials for difficult-to-treat APS patients. He has been a member of multiple APS-related national/international committees as well as an invited speaker at numerous conferences.

Dr. Erkan is also HSS Center Director for the Lupus Clinical Trials Consortium and is involved in multi-center pharmaceutical-sponsored clinical trials investigating new treatments for lupus patients.

Clinical Trials

• Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Multicenter Study To Evaluate The Efficacy and Safety of Two Doses of Ocrelizumab in Patients With WHO or ISN Class III or IV Nephritis Due To Systemic Lupus Erythematosus.
• A Randomized, Double Blind, Placebo Controlled, Multicenter Prospective Dose Finding Phase II/III Study with Atacicept Given Subcutaneously to Subjects having Recently Experienced a Flare of SLE3
• Cognitive Dysfunction, Diffusion Tensor Imaging and Functional Magnetic Resonance Imaging (MRI) in Antiphospholipid Antibody (aPL)-negative Systemic Lupus Erythematosus (SLE) versus aPL-positive non-SLE Patients
• Effects of Fluvastatin on Proinflammatory and Prothrombotic markers in Antiphospholipid Syndrome
• Autoimmune Disease Registry and Repository
• RITAPS: A Pilot Study Of Rituximab For The Anticoagulation-Resistant Manifestations Of Antiphospholipid Syndrome (APS)